
Immunoassay Control Set LumiraDx SARS-CoV-2 Ag Positive Level / Negative Level 4 X 0.5 mL
- The LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization ONLY:
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests
- This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2
- Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status; positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results, from patients with symptoms onset beyond twelve days, should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
- Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
- The LumiraDx SARS-CoV-2 Ag Quality Controls (hereafter referred to as Quality Controls) are liquid quality controls to be used with the LumiraDx Instrument (hereafter referred to as the Instrument) and the LumiraDx SARS-CoV-2 Ag Test (hereafter referred to as SARS-CoV-2 Ag Test)
- The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip
- The LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument
- Kit contents: 2 X 0.5ml vial SARS-CoV-2 Ag Positive Control, 2 X 0.5ml vial SARS-CoV-2 Ag Negative Control, 24 Transfer pipettes (20µl), LumiraDx SARS-CoV-2 Ag Quality Control Pack Insert
- Requires: LumiraDx Instrument, LumiraDx SARS-CoV-2 Ag Test Strips, and LumiraDx Connect– if connectivity required (refer to LumiraDx Connect User Manual)
Product Specs
| Item Number | 1176896 |
|---|---|
| Catalog Number | L016080109002 |
| UOM | EA |
| Level 1 Family Description | Lab-Non-Waived Lab |
| Level 2 Category Description | Lab-Immunoassay |
| Level 3 Group Description | Immunoassay Reagents |
| Level 4 Sub-Category Description | COVID - IA Cals/Ctrls |
| Application | Control Set |
| Brand | LumiraDx |
| Buy American Act (BAA) Compliant | No |
| Container Type | Vial |
| Country of Origin | Unknown |
| For Use With | For use in Conjunction with the LumiraDx SARS-CoV-2 Ag Test Strip System on the LumiraDx Instrument |
| Form | Liquid |
| Levels | Positive Level / Negative Level |
| Manufacturer | LumiraDx Inc |
| Manufacturer # | L016080109002 |
| McKesson # | 1197712 |
| Storage Requirements | Requires Refrigeration |
| Test Category | Respiratory |
| Test Name | SARS-CoV-2 Ag |
| Test Type | Immunoassay |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116128 |
| Volume | 4 X 0.5 mL |
- The LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization ONLY:
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests
- This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2
- Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status; positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results, from patients with symptoms onset beyond twelve days, should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
- Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
- The LumiraDx SARS-CoV-2 Ag Quality Controls (hereafter referred to as Quality Controls) are liquid quality controls to be used with the LumiraDx Instrument (hereafter referred to as the Instrument) and the LumiraDx SARS-CoV-2 Ag Test (hereafter referred to as SARS-CoV-2 Ag Test)
- The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip
- The LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument
- Kit contents: 2 X 0.5ml vial SARS-CoV-2 Ag Positive Control, 2 X 0.5ml vial SARS-CoV-2 Ag Negative Control, 24 Transfer pipettes (20µl), LumiraDx SARS-CoV-2 Ag Quality Control Pack Insert
- Requires: LumiraDx Instrument, LumiraDx SARS-CoV-2 Ag Test Strips, and LumiraDx Connect– if connectivity required (refer to LumiraDx Connect User Manual)
Product Specs
| Item Number | 1176896 |
|---|---|
| Catalog Number | L016080109002 |
| UOM | EA |
| Level 1 Family Description | Lab-Non-Waived Lab |
| Level 2 Category Description | Lab-Immunoassay |
| Level 3 Group Description | Immunoassay Reagents |
| Level 4 Sub-Category Description | COVID - IA Cals/Ctrls |
| Application | Control Set |
| Brand | LumiraDx |
| Buy American Act (BAA) Compliant | No |
| Container Type | Vial |
| Country of Origin | Unknown |
| For Use With | For use in Conjunction with the LumiraDx SARS-CoV-2 Ag Test Strip System on the LumiraDx Instrument |
| Form | Liquid |
| Levels | Positive Level / Negative Level |
| Manufacturer | LumiraDx Inc |
| Manufacturer # | L016080109002 |
| McKesson # | 1197712 |
| Storage Requirements | Requires Refrigeration |
| Test Category | Respiratory |
| Test Name | SARS-CoV-2 Ag |
| Test Type | Immunoassay |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116128 |
| Volume | 4 X 0.5 mL |
Original: $64.98
-65%$64.98
$22.74Description
- The LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization ONLY:
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests
- This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2
- Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status; positive results do not rule out bacterial infection or co-infection with other viruses
- Negative results, from patients with symptoms onset beyond twelve days, should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
- Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
- The LumiraDx SARS-CoV-2 Ag Quality Controls (hereafter referred to as Quality Controls) are liquid quality controls to be used with the LumiraDx Instrument (hereafter referred to as the Instrument) and the LumiraDx SARS-CoV-2 Ag Test (hereafter referred to as SARS-CoV-2 Ag Test)
- The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip
- The LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument
- Kit contents: 2 X 0.5ml vial SARS-CoV-2 Ag Positive Control, 2 X 0.5ml vial SARS-CoV-2 Ag Negative Control, 24 Transfer pipettes (20µl), LumiraDx SARS-CoV-2 Ag Quality Control Pack Insert
- Requires: LumiraDx Instrument, LumiraDx SARS-CoV-2 Ag Test Strips, and LumiraDx Connect– if connectivity required (refer to LumiraDx Connect User Manual)
Product Specs
| Item Number | 1176896 |
|---|---|
| Catalog Number | L016080109002 |
| UOM | EA |
| Level 1 Family Description | Lab-Non-Waived Lab |
| Level 2 Category Description | Lab-Immunoassay |
| Level 3 Group Description | Immunoassay Reagents |
| Level 4 Sub-Category Description | COVID - IA Cals/Ctrls |
| Application | Control Set |
| Brand | LumiraDx |
| Buy American Act (BAA) Compliant | No |
| Container Type | Vial |
| Country of Origin | Unknown |
| For Use With | For use in Conjunction with the LumiraDx SARS-CoV-2 Ag Test Strip System on the LumiraDx Instrument |
| Form | Liquid |
| Levels | Positive Level / Negative Level |
| Manufacturer | LumiraDx Inc |
| Manufacturer # | L016080109002 |
| McKesson # | 1197712 |
| Storage Requirements | Requires Refrigeration |
| Test Category | Respiratory |
| Test Name | SARS-CoV-2 Ag |
| Test Type | Immunoassay |
| Trade Agreement Act (TAA) Compliant | No |
| UNSPSC Code | 41116128 |
| Volume | 4 X 0.5 mL |



